We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

155 hedge funds and large institutions have $297M invested in Alaunos Therapeutics in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 46 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

26% more call options, than puts

Call options by funds: $3.19M | Put options by funds: $2.54M

3% more funds holding

Funds holding: 151 → 155 (+4)

5% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 44

0.02% less ownership

Funds ownership: 0.36% → 0.35% (-0.02%)

30% less capital invested

Capital invested by funds: $422M → $297M (-$125M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
155
Holders Change
+4
Holders Change %
+2.65%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
25
Increased
46
Reduced
44
Closed
19
Calls
$3.19M
Puts
$2.54M
Net Calls
+$660K
Net Calls Change
-$1.45M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.57M
2
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$1.47M
3
DCM
Discovery Capital Management
Connecticut
+$1.36M
4
Millennium Management
Millennium Management
New York
+$1.15M
5
N
Nuveen
North Carolina
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$7.11M
2
MVP
Miller Value Partners
Florida
-$4.72M
3
State Street
State Street
Massachusetts
-$4.17M
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$1.56M
5
AA
ALPS Advisors
Colorado
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
X
126
Xponance
Pennsylvania
$29K +$34.5K +74 New
ODG
127
O'Dell Group
Ohio
$27K – – –
CC
128
Centiva Capital
New York
$27K +$31.7K +68 New
BNP Paribas Financial Markets
129
BNP Paribas Financial Markets
France
$24.2K -$180K -385 -86%
CAPTRUST Financial Advisors
130
CAPTRUST Financial Advisors
North Carolina
$18K -$2.33K -5 -10%
Macquarie Group
131
Macquarie Group
Australia
$16K – – –
CFA
132
Carroll Financial Associates
North Carolina
$15K – – –
NFSG
133
Newbridge Financial Services Group
Florida
$15K – – –
MAM
134
Meeder Asset Management
Ohio
$14K – – –
LWA
135
Lenox Wealth Advisors
New York
$13K – – –
PCM
136
Penserra Capital Management
California
$12K +$467 +1 +3%
KFI
137
Key Financial Inc
Pennsylvania
$8K – – –
PHK
138
Point72 Hong Kong
Hong Kong
$8K +$9.8K +21 New
COCM
139
Charter Oak Capital Management
New Hampshire
$7K – – –
OSAM
140
O'Shaughnessy Asset Management
Connecticut
$7K – – –
APA
141
American Portfolios Advisors
New York
$4.75K – – –
US Bancorp
142
US Bancorp
Minnesota
$4K +$4.67K +10 New
ADL
143
Asset Dedication LLC
California
$3K +$3.73K +8 New
Rockefeller Capital Management
144
Rockefeller Capital Management
New York
$2K – – –
TWA
145
TCI Wealth Advisors
Arizona
$2K – – –
CG
146
Cutler Group
California
$2K +$3.27K +7 New
GWM
147
Geneos Wealth Management
Colorado
$1K -$6.07K -13 -81%
Daiwa Securities Group
148
Daiwa Securities Group
Japan
$1K – – –
FF
149
FourThought Financial
Florida
$1K – – –
JFA
150
JNBA Financial Advisors
Minnesota
$1K – – –
3 4 5
6
7

TCRT Hedge Fund Activity: Q2 2021 in Review

155 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q2 2021, worth a combined $297M — down 30% from $422M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TCRT positions and 19 closed out — a net gain of 6 holders — while 46 added to existing stakes and 44 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.57M. The largest seller was BlackRock, cutting an estimated $7.11M.

  • 155 institutional investors held Alaunos Therapeutics (TCRT) as of Q2 2021, up from 151 in Q1 2021.
  • Funds reported $297M of Alaunos Therapeutics stock for Q2 2021, down 30% quarter-over-quarter.
  • 25 funds opened new Alaunos Therapeutics positions in Q2 2021 and 19 closed out, a net change of +6 holders.
  • The largest Alaunos Therapeutics buyer in Q2 2021 was Renaissance Technologies, an estimated $1.57M added.
  • The largest Alaunos Therapeutics seller in Q2 2021 was BlackRock, an estimated $7.11M sold.

Based on aggregated 13F filings for Q2 2021.